Dr. Wong Yau Kar
Independent non-executive Director
chemical
SINOPEC KANTONS HOLDING LIMITED
China
Biography
Dr. Wong Yau Kar, David, BBS, JP, has been an independent non-executive Director since 14 January 2014. Dr. Wong received a doctorate in Economics from the University of Chicago in 1987. Dr. Wong has extensive experience in manufacturing, direct investment and international trade. Dr. Wong is active in public service. He is a Hong Kong deputy of the 12th National People’s Congress of the People’s Republic of China (第å二屆全國人民代表大會). He is also Chairman of the Land and Development Advisory Committee, Mandatory Provident Fund Schemes Authority and Protection of Wages on Insolvency Fund Board. Dr. Wong was appointed a Justice of Peace (JP) in 2010 and was awarded a Bronze Bauhinia Star (BBS) in 2012 for his valuable contribution to the society. Dr. Wong is currently an independent non-executive director of China Juhao Health Industry Corporation Limited (Stock code: 419), China WindPower Group Limited (Stock code: 182), Redco Properties Group Limited (Stock code: 1622), ReOrient Group Limited (Stock code: 376) and Shenzhen Investment Limited (Stock code: 604), the shares of which are listed on the Main Board of the Stock Exchange.
Research Interest
Sinopec Kantons Holdings Limited (“Kantons Holdings”) was established in Bermuda in March 1998 and was listed on the Hong Kong Stock Exchange on 25 June,1999 (Stock Code: 00934). Currently, the total issued share capital of Kantons Holdings is 2,486.16 million shares of which 1,500 million shares are held by Sinopec Kantons International Limited, representing 60.34% and 986.16 million shares are public float, representing 39.66%. The entire share capital of Sinopec Kantons International Limited is held by China International United Petroleum & Chemical Co.Ltd.(Unipec), a wholly owned subsidiary of China Petroleum & Chemical Corporation (“Sinopec”).